%T Preclinical stages in subjects at risk for neurological disorders: Can PET FDG tell us more?
%P 112-114
%I Springer
%A Nina P. Azari
%A Pietro Pietrini
%N 2
%L eprints3343
%V 242
%R 10.1007/BF00887827
%D 1995
%J Journal of Neurology